SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Holy shit! Wow, FDA hires Grail Sipes, former

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Biobillionair Member Profile
 
Followed By 65
Posts 9,556
Boards Moderated 1
Alias Born 01/12/13
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2017 9:07:06 AM
Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care "GlobeNewswire Inc." - 5/18/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:26:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:26:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:25:42 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:24:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:23:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:14:55 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/3/2017 7:08:34 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/3/2017 7:02:08 AM
Amarin Reports First Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 5/3/2017 5:00:00 AM
Amarin to Report First Quarter 2017 Results and Host Conference Call on May 3, 2017 "GlobeNewswire Inc." - 4/25/2017 4:30:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/21/2017 6:48:13 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2017 5:03:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2017 5:01:33 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/27/2017 4:18:32 PM
Amarin Reaches the Onset of Approximately 80% of the Target Aggregate Number of Primary Major Adverse Cardiovascular Events W... "GlobeNewswire Inc." - 3/16/2017 5:00:00 AM
Amarin Announces Publication of REDUCE-IT Cardiovascular Outcomes Study Rationale and Design in Clinical Cardiology "GlobeNewswire Inc." - 3/15/2017 9:56:43 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) "Edgar (US Regulatory)" - 3/1/2017 5:23:20 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) "Edgar (US Regulatory)" - 3/1/2017 5:21:36 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/1/2017 5:12:09 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/28/2017 6:31:56 AM
Amarin Reports Record Fourth Quarter and Full Year 2016 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 2/28/2017 6:00:00 AM
Amarin to Report Fourth Quarter and Full Year 2016 Results and Host Conference Call on February 28th, 2017 "GlobeNewswire Inc." - 2/22/2017 8:00:00 AM
Amarin to Participate in the Leerink Partners 6th Annual Global Healthcare Conference "GlobeNewswire Inc." - 2/9/2017 7:50:18 AM
Biobillionair   Friday, 10/31/14 10:55:20 PM
Re: None
Post # of 107009 
Holy shit! Wow, FDA hires Grail Sipes, former partner at Covington's, as CDER policy director. Definitely a sign!
New CDER Compliance Director is from DOJ

Office of Regulatory Policy
Director
Grail Sipes, J.D.
(DKKNAA)

Grail wife of Christopher Sipes, attorney who represent Amarin at June OB meeting and NCE suit !!!


Kurt R. Karst, Robert Dormer, Josephine Torrente (Hyman, Phelps & McNamara); Joseph Kennedy, Steven Ketchum, Peggy Berry, Paresh Soni, Barbara Kurys (Amarin); Christopher Sipes (Covington & Burling)


http://www.fda.gov/AboutFDA/CentersOffices/OrganizationCharts/ucm184745.htm

Office of Compliance
Director
Cynthia Schnedar


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist